HIV Therapeutics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251365 | Category: Medical Care | Pages: 67 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
This report aims to provide a comprehensive presentation of the global market for HIV Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Therapeutics. This report contains market size and forecasts of HIV Therapeutics in global, including the following market information:
Global HIV Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global HIV Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Type, 2022 (%)
    Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
    Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Entry and Fusion Inhibitors
    Protease Inhibitors (PIs)
    Integrase Inhibitors
    Coreceptor Antagonists
Global HIV Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Clinics
    Labs
Global HIV Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global HIV Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies HIV Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Boehringer Ingelheim International GmbH
    Merck & Co.
    ViiV Healthcare
    AbbVie
    F. Hoffmann-La Roche Ltd.
    Teva Pharmaceutical Industries Ltd.
    Bristol-Myers Squibb
    Gilead Sciences
    Johnson & Johnson
    Cipla Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of HIV Therapeutics, market overview.
Chapter 2: Global HIV Therapeutics market size in revenue.
Chapter 3: Detailed analysis of HIV Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HIV Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 HIV Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global HIV Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global HIV Therapeutics Overall Market Size
    2.1 Global HIV Therapeutics Market Size: 2022 VS 2029
    2.2 Global HIV Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top HIV Therapeutics Players in Global Market
    3.2 Top Global HIV Therapeutics Companies Ranked by Revenue
    3.3 Global HIV Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 HIV Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies HIV Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 HIV Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 HIV Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 HIV Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global HIV Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
        4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
        4.1.4 Entry and Fusion Inhibitors
        4.1.5 Protease Inhibitors (PIs)
        4.1.6 Integrase Inhibitors
        4.1.7 Coreceptor Antagonists
    4.2 By Type - Global HIV Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global HIV Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global HIV Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global HIV Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global HIV Therapeutics Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Labs
    5.2 By Application - Global HIV Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global HIV Therapeutics Revenue, 2018-2023
        5.2.2 By Application - Global HIV Therapeutics Revenue, 2024-2029
        5.2.3 By Application - Global HIV Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global HIV Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global HIV Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global HIV Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global HIV Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global HIV Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America HIV Therapeutics Revenue, 2018-2029
        6.3.2 US HIV Therapeutics Market Size, 2018-2029
        6.3.3 Canada HIV Therapeutics Market Size, 2018-2029
        6.3.4 Mexico HIV Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe HIV Therapeutics Revenue, 2018-2029
        6.4.2 Germany HIV Therapeutics Market Size, 2018-2029
        6.4.3 France HIV Therapeutics Market Size, 2018-2029
        6.4.4 U.K. HIV Therapeutics Market Size, 2018-2029
        6.4.5 Italy HIV Therapeutics Market Size, 2018-2029
        6.4.6 Russia HIV Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries HIV Therapeutics Market Size, 2018-2029
        6.4.8 Benelux HIV Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia HIV Therapeutics Revenue, 2018-2029
        6.5.2 China HIV Therapeutics Market Size, 2018-2029
        6.5.3 Japan HIV Therapeutics Market Size, 2018-2029
        6.5.4 South Korea HIV Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia HIV Therapeutics Market Size, 2018-2029
        6.5.6 India HIV Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America HIV Therapeutics Revenue, 2018-2029
        6.6.2 Brazil HIV Therapeutics Market Size, 2018-2029
        6.6.3 Argentina HIV Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa HIV Therapeutics Revenue, 2018-2029
        6.7.2 Turkey HIV Therapeutics Market Size, 2018-2029
        6.7.3 Israel HIV Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia HIV Therapeutics Market Size, 2018-2029
        6.7.5 UAE HIV Therapeutics Market Size, 2018-2029
7 HIV Therapeutics Companies Profiles
    7.1 Boehringer Ingelheim International GmbH
        7.1.1 Boehringer Ingelheim International GmbH Company Summary
        7.1.2 Boehringer Ingelheim International GmbH Business Overview
        7.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Major Product Offerings
        7.1.4 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
    7.2 Merck & Co.
        7.2.1 Merck & Co. Company Summary
        7.2.2 Merck & Co. Business Overview
        7.2.3 Merck & Co. HIV Therapeutics Major Product Offerings
        7.2.4 Merck & Co. HIV Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Merck & Co. Key News & Latest Developments
    7.3 ViiV Healthcare
        7.3.1 ViiV Healthcare Company Summary
        7.3.2 ViiV Healthcare Business Overview
        7.3.3 ViiV Healthcare HIV Therapeutics Major Product Offerings
        7.3.4 ViiV Healthcare HIV Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 ViiV Healthcare Key News & Latest Developments
    7.4 AbbVie
        7.4.1 AbbVie Company Summary
        7.4.2 AbbVie Business Overview
        7.4.3 AbbVie HIV Therapeutics Major Product Offerings
        7.4.4 AbbVie HIV Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 AbbVie Key News & Latest Developments
    7.5 F. Hoffmann-La Roche Ltd.
        7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
        7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
        7.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Major Product Offerings
        7.5.4 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
    7.6 Teva Pharmaceutical Industries Ltd.
        7.6.1 Teva Pharmaceutical Industries Ltd. Company Summary
        7.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Major Product Offerings
        7.6.4 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
    7.7 Bristol-Myers Squibb
        7.7.1 Bristol-Myers Squibb Company Summary
        7.7.2 Bristol-Myers Squibb Business Overview
        7.7.3 Bristol-Myers Squibb HIV Therapeutics Major Product Offerings
        7.7.4 Bristol-Myers Squibb HIV Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Bristol-Myers Squibb Key News & Latest Developments
    7.8 Gilead Sciences
        7.8.1 Gilead Sciences Company Summary
        7.8.2 Gilead Sciences Business Overview
        7.8.3 Gilead Sciences HIV Therapeutics Major Product Offerings
        7.8.4 Gilead Sciences HIV Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 Gilead Sciences Key News & Latest Developments
    7.9 Johnson & Johnson
        7.9.1 Johnson & Johnson Company Summary
        7.9.2 Johnson & Johnson Business Overview
        7.9.3 Johnson & Johnson HIV Therapeutics Major Product Offerings
        7.9.4 Johnson & Johnson HIV Therapeutics Revenue in Global Market (2018-2023)
        7.9.5 Johnson & Johnson Key News & Latest Developments
    7.10 Cipla Limited
        7.10.1 Cipla Limited Company Summary
        7.10.2 Cipla Limited Business Overview
        7.10.3 Cipla Limited HIV Therapeutics Major Product Offerings
        7.10.4 Cipla Limited HIV Therapeutics Revenue in Global Market (2018-2023)
        7.10.5 Cipla Limited Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

HIV Therapeutics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?